Morgan Stanley’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.76K Hold
3,105
﹤0.01% 7208
2025
Q4
$3.88K Hold
3,105
﹤0.01% 7113
2025
Q3
$4K Hold
3,105
﹤0.01% 7151
2025
Q2
$6.05K Hold
3,105
﹤0.01% 6987
2025
Q1
$7.89K Sell
3,105
-911
-23% -$2.2K ﹤0.01% 6873
2024
Q4
$8.76K Buy
4,016
+3,986
+13,287% +$9.34K ﹤0.01% 6855
2024
Q3
$94 Hold
30
﹤0.01% 7450
2024
Q2
$89 Hold
30
﹤0.01% 7376
2024
Q1
$183 Sell
30
-30
-50% -$215 ﹤0.01% 7321
2023
Q4
$598 Sell
60
-6
-9% -$49 ﹤0.01% 7259
2023
Q3
$423 Hold
66
﹤0.01% 7323
2023
Q2
$2.63K Hold
66
﹤0.01% 7136
2023
Q1
$1.92K Hold
66
﹤0.01% 7244
2022
Q4
$2.05K Hold
66
﹤0.01% 7366
2022
Q3
$2K Hold
66
﹤0.01% 7446
2022
Q2
$1K Hold
66
﹤0.01% 7657
2022
Q1
$2K Hold
66
﹤0.01% 7723
2021
Q4
$2K Sell
66
-26
-28% -$954 ﹤0.01% 7780
2021
Q3
$4K Hold
92
﹤0.01% 7534
2021
Q2
$5K Buy
92
+26
+39% +$1.58K ﹤0.01% 7370
2021
Q1
$4K Hold
66
﹤0.01% 7141
2020
Q4
$3K Buy
66
+30
+83% +$1.2K ﹤0.01% 6838
2020
Q3
$1K Hold
36
﹤0.01% 6645
2020
Q2
$1K Sell
36
-43
-54% -$2.33K ﹤0.01% 6510
2020
Q1
$4K Hold
79
﹤0.01% 6259
2019
Q4
$4K Buy
79
+43
+119% +$2.53K ﹤0.01% 6416
2019
Q3
$2K Buy
+36
New +$2.58K ﹤0.01% 6467

Other funds holding BCDA

Morgan Stanley's BCDA Position: Q1 2026 in Review

Morgan Stanley held its BioCardia (BCDA) position steady in Q1 2026 at 3,105 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #7208.

Morgan Stanley first reported a position in BCDA in Q3 2019 and has held it in 27 quarters since. The position peaked at $8.76K in Q4 2024. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Morgan Stanley held 3,105 shares of BioCardia worth $3.76K as of Q1 2026.
  • Morgan Stanley left its BioCardia share count unchanged in Q1 2026.
  • BioCardia made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7208 holding.
  • Morgan Stanley first reported a position in BioCardia in Q3 2019 and has held it in 27 quarters since.
  • Morgan Stanley's BioCardia position peaked at $8.76K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.